CLDN1 (Claudin 1): Tight Junction Protein in Barrier Function and Disease

A comprehensive biomedical overview of CLDN1, its genomic context, expression, mutations, and clinical significance.

Gene Information Card

Symbol CLDN1
Full Name Claudin 1
Gene Type protein-coding
Chromosomal Location 3q28
NCBI Gene ID 9076 ncbi.nlm.nih.gov/gene/9076
Ensembl ID ENSG00000163347
UniProt ID O95832
OMIM ID 603718
HGNC ID 2048
Aliases SEMP1, ILVASC, CLD1

Description

CLDN1 encodes claudin-1, a major integral membrane protein of tight junctions. It is essential for paracellular barrier function in epithelial and endothelial cells, contributing to tissue integrity and selective ion transport. CLDN1 also serves as a receptor for hepatitis C virus (HCV) entry into hepatocytes. Mutations in CLDN1 cause neonatal ichthyosis-sclerosing cholangitis syndrome (NISCH), and altered expression is linked to various cancers and inflammatory conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neonatal ichthyosis-sclerosing cholangitis syndrome (NISCH) Loss-of-function mutations (e.g., frameshift, nonsense) lead to defective tight junctions in skin and bile ducts, causing ichthyosis and cholangitis. OMIM #607626; ClinVar; PMID: 15108291
Hepatitis C virus (HCV) infection CLDN1 acts as a co-receptor for HCV entry; genetic variants may influence susceptibility or treatment response. PMID: 17981119; PMID: 22080952
Hepatocellular carcinoma (HCC) Downregulation of CLDN1 is associated with epithelial-mesenchymal transition (EMT) and poor prognosis; loss of tight junction integrity promotes invasion. PMID: 21516114; PMID: 26014203
Colorectal cancer Reduced CLDN1 expression correlates with tumor progression and metastasis; aberrant localization (cytoplasmic/nuclear) is observed. PMID: 19116627; PMID: 23563179
Inflammatory bowel disease (IBD) Altered CLDN1 expression disrupts intestinal barrier, contributing to inflammation and disease severity. PMID: 19052199; PMID: 23349065

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Skin 8.9 Low
Kidney 7.2 Low
Colon 6.8 Low
Lung 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver) 15.3 High expression; used in HCV entry studies
Caco-2 (colon) 12.1 High expression; intestinal barrier model
A549 (lung) 3.2 Low expression
MCF7 (breast) 1.5 Very low expression
HeLa (cervix) 0.8 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.354delC (p.Pro118LeufsTer24) Frameshift Rare (NISCH) Loss of function; truncated protein
c.200C>T (p.Pro67Leu) Missense Rare (NISCH) Loss of function; impaired trafficking
c.1A>G (p.Met1Val) Start codon loss Rare (NISCH) Loss of function; no protein synthesis
c.487C>T (p.Arg163Ter) Nonsense Rare (NISCH) Loss of function; truncated protein
c.53C>T (p.Ser18Phe) Missense Rare (NISCH) Loss of function; altered localization
Mutation functional classification

Loss of Function (LOF)

Most CLDN1 mutations are loss-of-function, leading to defective tight junctions and NISCH syndrome. These include frameshift, nonsense, and missense variants that impair protein synthesis, trafficking, or assembly.

Gain of Function (GOF)

No clear gain-of-function mutations have been reported for CLDN1. Overexpression in some cancers may be considered a gain-of-function at the expression level, but not due to specific mutations.

Dominant Negative (DN)

No dominant-negative mutations have been documented. CLDN1 mutations are typically autosomal recessive, requiring biallelic loss.

Gene Ontology (GO)

• protein binding • identical protein binding
• structural molecule activity • cell-cell junction
• tight junction • plasma membrane
• apicolateral plasma membrane • bicellular tight junction
• cell-cell adhesion • calcium-independent cell-cell adhesion
• establishment of skin barrier • response to virus
• hepatitis C virus entry into host cell

Pathways

Tight junction pathway (KEGG: hsa04530)
Adherens junction (related)
Hepatitis C virus entry pathway (KEGG: hsa05160)
Epithelial cell signaling in Helicobacter pylori infection (related)

Protein Summary

Claudin-1 is a 211-amino-acid protein with four transmembrane domains, two extracellular loops, and cytoplasmic N- and C-termini. It forms the backbone of tight junction strands, interacting with other claudins and scaffolding proteins like ZO-1. The extracellular loops mediate cell-cell adhesion and serve as a binding site for HCV envelope glycoproteins. Post-translational modifications include phosphorylation, which regulates tight junction assembly. Claudin-1 is critical for epidermal barrier function and hepatic bile duct integrity.

Related Products

Product name Cat.No. Species Gene ID
CLDN1 Knockout HEK293 Cell Line EDJ-KQ3729 Human 9076 Details Get a Quote
CLDN12 Knockout HEK293 Cell Line EDJ-KQ5771 Human 9069 Details Get a Quote
CLDN10 Knockout HEK293 Cell Line EDJ-KQ6453 Human 9071 Details Get a Quote
CLDN16 Knockout HEK293 Cell Line EDJ-KQ7130 Human 10686 Details Get a Quote
CLDN15 Knockout HEK293 Cell Line EDJ-KQ7473 Human 24146 Details Get a Quote
CLDN14 Knockout HEK293 Cell Line EDJ-KQ8073 Human 23562 Details Get a Quote
CLDN17 Knockout HEK293 Cell Line EDJ-KQ8504 Human 26285 Details Get a Quote
CLDN19 Knockout HEK293 Cell Line EDJ-KQ11118 Human 149461 Details Get a Quote
CLDN18 Knockout HEK293 Cell Line EDJ-KQ17692 Human 51208 Details Get a Quote
CLDN15 Knockout A-549 Cell Line EDJ-KQ34035 Human 24146 Details Get a Quote
CLDN15 Knockout HCT 116 Cell Line EDJ-KQ34037 Human 24146 Details Get a Quote
CLDN15 Knockout HeLa Cell Line EDJ-KQ34038 Human 24146 Details Get a Quote
CLDN1 Knockout A-549 Cell Line EDJ-KQ25778 Human 9076 Details Get a Quote
CLDN1 Knockout HeLa Cell Line EDJ-KQ25779 Human 9076 Details Get a Quote
CLDN12 Knockout A-549 Cell Line EDJ-KQ30518 Human 9069 Details Get a Quote
Displaying Records 1 To 15 Of 41 Records
Contact Us
*
*
*
*
How did you hear about us: